Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Quinazolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel FeCl3-catalyzed route for 2-CF3 quinazolinones. High yield, scalable process for API intermediates. Cost-effective manufacturing solution.
Novel Pd-catalyzed carbonylation method for 2-trifluoromethyl quinazolinones offers high yields and broad substrate scope, enabling cost-effective manufacturing of drug molecules like Rutaecarpine.
Patent CN111675662B reveals a novel FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel FeCl3-catalyzed route offers high yields and scalability for drug discovery, reducing costs in API manufacturing significantly.
Patent CN112480015B details a Pd-catalyzed one-pot synthesis. Offers cost reduction in API manufacturing and high-purity pharmaceutical intermediates with scalable protocols.
Patent CN112125856A details a novel Pd-catalyzed carbonylation for 2-trifluoromethyl quinazolinones, offering safer synthesis and cost reduction in API manufacturing.
Novel Pd-catalyzed one-pot method for 2-CF3 quinazolinones. High yield, scalable process for API intermediates. Cost-effective supply chain solution.
Novel FeCl3-catalyzed route offers high yield and scalability for quinazolinone derivatives, reducing costs for API manufacturers.
Patent CN112125856A details a safe, scalable synthesis of 2-trifluoromethyl quinazolinones using solid CO surrogates, offering significant cost and safety advantages for pharmaceutical manufacturing.
Novel Pd-catalyzed carbonylation route for quinazolinones. High yield, scalable process for drug molecules like Rutaecarpine.
Patent CN112480015B details a scalable one-pot method for 2-trifluoromethyl quinazolinones, offering cost reduction in pharmaceutical intermediate manufacturing via safe carbonylation.
Patent CN112480015B reveals a Pd-catalyzed one-pot method for quinazolinones. Offers cost-effective, scalable routes for API intermediates.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant supply chain advantages for pharmaceutical intermediates.
Patent CN111675662B reveals a scalable iron-catalyzed route to 2-trifluoromethyl quinazolinones, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones. High efficiency, broad substrate scope, cost-effective manufacturing for pharmaceutical intermediates.
Novel one-pot method for 2-trifluoromethyl quinazolinones using nitro compounds. High yield, scalable process for pharmaceutical intermediates.
Patent CN112480015B details a Pd-catalyzed carbonylation method for quinazolinones. Offers high yield, mild conditions, and scalable routes for API intermediates.
Patent CN112480015B details a novel one-pot carbonylation method for high-purity quinazolinone intermediates, offering significant cost reduction and scalability for API manufacturing.
Patent CN113045503B details a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN112480015B reveals a Pd-catalyzed one-pot method for quinazolinones, offering cost-effective routes for API manufacturing and reliable supply chain solutions.